Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

No longer available × Rose Bengal × Dermatologic × Clear all

Status

Completed 2 Unknown 1 Terminated 1 No longer available 1

Sponsor Class

Study Type

Expanded_access 1

Sponsor

Cancer Type

Conditions

Cutaneous or Subcutaneous Tumors Where There is no Comparable or Satisfactory 1

Interventions

trametinib 3 dabrafenib 3 talimogene laherparepvec 2 pembrolizumab 2 Nivolumab 2 Ipilimumab 2 pegilodecakin 1 omaveloxolone 1 methyl 5-aminolevulinate 1 efineptakin alfa 1 aldesleukin 1 Rose Bengal 1 Melphalan 1 Cyclophosphamide 1 Brentuximab Vedotin 1 AM0010 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01260779 2016-07-11

Expanded Access Protocol for PV-10 for Cutaneous or Subcutaneous Tumors

Provectus Pharmaceuticals

No longer available

Cutaneous or Subcutaneous Tumors Where There is no Comparable or Satisfactory

Data powered by HemOnc (CC BY 4.0) Colophon ⚡